Literature DB >> 20529008

Survey of transfusion policies at US and Canadian children's hospitals in 2008 and 2009.

Philip C Spinella1, Alex Dressler, Marisa Tucci, Christopher L Carroll, Rosa Sanchez Rosen, Heather Hume, Steven R Sloan, Jacques Lacroix.   

Abstract

BACKGROUND: Previous surveys have reported variation in transfusion practice or policies in specific pediatric populations. Our objective was to determine the current transfusion policies in US and Canadian children's hospitals for both neonatal and pediatric general populations. STUDY DESIGN AND METHODS: US and Canadian blood bank (BB) personnel at children's hospitals that provide blood products between the dates of October 2008 and January 2009 were surveyed.
RESULTS: Of the 90 US and Canadian children's hospitals identified, 51 (56.7%) blood bankers or their designees responded. There were 42 of 51 (82.4%) respondents from the United States and 9 of 51 (17.6%) from Canada. There was wide variation in beliefs regarding the effect of red blood cell (RBC) storage age on outcomes with 66.6% of respondents interested in a prospective randomized trial in critically ill children. There was also wide variation in policies restricting the storage age of RBCs according to patient age and clinical condition. In the United States 28 of 33 (84.8%) respondents provide universal leukoreduction of RBCs whereas it is 9 of 9 (100%) in Canada. Variation of policies existed for RBC irradiation and washing. The majority of respondents indicated that RBC transfusions were audited if the pretransfusion hemoglobin level was more than 8 to 10mg/dL. Fresh whole blood is available at 6 of 40 (15%) responding children's hospitals.
CONCLUSIONS: There is a wide variation in BB policies regarding RBC transfusions at children's hospitals in the United States and Canada. Prospective randomized controlled trials are needed to allow for evidence-based standards of care regarding RBC transfusions.
© 2010 American Association of Blood Banks.

Entities:  

Mesh:

Year:  2010        PMID: 20529008     DOI: 10.1111/j.1537-2995.2010.02708.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  24 in total

1.  Transfusion complications in thalassemia patients: a report from the Centers for Disease Control and Prevention (CME).

Authors:  Elliott Vichinsky; Lynne Neumayr; Sean Trimble; Patricia J Giardina; Alan R Cohen; Thomas Coates; Jeanne Boudreaux; Ellis J Neufeld; Kristy Kenney; Althea Grant; Alexis A Thompson
Journal:  Transfusion       Date:  2013-07-25       Impact factor: 3.157

2.  The state of the science of whole blood: lessons learned at Mayo Clinic.

Authors:  James R Stubbs; Martin D Zielinski; Donald Jenkins
Journal:  Transfusion       Date:  2016-04       Impact factor: 3.157

Review 3.  The intensive care medicine clinical research agenda in paediatrics.

Authors:  Mark J Peters; Andrew Argent; Marino Festa; Stéphane Leteurtre; Jefferson Piva; Ann Thompson; Douglas Willson; Pierre Tissières; Marisa Tucci; Jacques Lacroix
Journal:  Intensive Care Med       Date:  2017-03-17       Impact factor: 17.440

4.  Red blood cell storage duration is not associated with clinical outcomes for acute chest syndrome in children with sickle cell disease.

Authors:  Melanie E Fields; Monica L Hulbert; Ling Chen; Ari N Berlin; Ron Jackups; Philip C Spinella
Journal:  Transfusion       Date:  2015-05-30       Impact factor: 3.157

5.  Absence of transfusion-associated microchimerism in pediatric and adult recipients of leukoreduced and gamma-irradiated blood components.

Authors:  Rosa Sanchez; Tzong-Hae Lee; Li Wen; Leilani Montalvo; Cathy Schechterly; Camilla Colvin; Harvey J Alter; Naomi L C Luban; Michael P Busch
Journal:  Transfusion       Date:  2011-10-07       Impact factor: 3.157

Review 6.  One size will never fit all: the future of research in pediatric transfusion medicine.

Authors:  Cassandra D Josephson; Traci Heath Mondoro; Daniel R Ambruso; Rosa Sanchez; Steven R Sloan; Naomi L C Luban; John A Widness
Journal:  Pediatr Res       Date:  2014-08-13       Impact factor: 3.756

7.  Prevention of transfusion-transmitted cytomegalovirus in low-birth weight infants (≤1500 g) using cytomegalovirus-seronegative and leukoreduced transfusions.

Authors:  Cassandra D Josephson; Marta-Inés Castillejo; Angela M Caliendo; Edmund K Waller; James Zimring; Kirk A Easley; Michael Kutner; Christopher D Hillyer; John D Roback
Journal:  Transfus Med Rev       Date:  2011-02-23

8.  Cytomegalovirus infection among infants in California neonatal intensive care units, 2005-2010.

Authors:  Tatiana M Lanzieri; Stephanie R Bialek; Mihoko V Bennett; Jeffrey B Gould
Journal:  J Perinat Med       Date:  2014-05       Impact factor: 1.901

Review 9.  Transfusion in Haemoglobinopathies: Review and recommendations for local blood banks and transfusion services in Oman.

Authors:  Arwa Z Al-Riyami; Shahina Daar
Journal:  Sultan Qaboos Univ Med J       Date:  2018-04-04

10.  Incidence and acute complications of asymptomatic central venous catheter-related deep venous thrombosis in critically ill children.

Authors:  Edward Vincent S Faustino; Philip C Spinella; Simon Li; Matthew G Pinto; Petronella Stoltz; Joana Tala; Mary Elizabeth Card; Veronika Northrup; Kenneth E Baker; T Rob Goodman; Lei Chen; Cicero T Silva
Journal:  J Pediatr       Date:  2012-08-09       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.